Cell Ready, LLC completed the acquisition of Certain Cell Manufacturing Assets of Marker Therapeutics, Inc.
Cell Ready, LLC completed the acquisition of Certain Cell Manufacturing Assets from Marker Therapeutics, Inc. on June 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.17 USD | +4.77% | -2.34% | -24.18% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
1st Jan change | Capi. | |
---|---|---|
-24.18% | 37.17M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.39% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |